• <dfn id="q240u"></dfn>
    • SAG Hydrochloride

      SAG (Smoothened Agonist) HCl是一種細(xì)胞滲透性Smoothened (Smo)激動劑,其在Shh-LIGHT2細(xì)胞中的EC50約為3 nM。

      SAG Hydrochloride Chemical Structure

      SAG Hydrochloride Chemical Structure

      CAS: 2095432-58-7

      規(guī)格 價格 庫存 購買數(shù)量
      10mM (1mL in DMSO) 2432.43 現(xiàn)貨
      2mg 954.43 現(xiàn)貨
      5mg 2024.65 現(xiàn)貨
      25mg 6110.42 現(xiàn)貨
      100mg 7944.3 現(xiàn)貨
      1g 57248.1 現(xiàn)貨
      更大包裝 有超大折扣

      400-668-6834

      [email protected]

      免費(fèi)分裝
      免費(fèi)預(yù)溶

      相關(guān)信號通路圖

      細(xì)胞實(shí)驗(yàn)數(shù)據(jù)示例

      細(xì)胞系 實(shí)驗(yàn)類型 給藥濃度 孵育時間 活性描述 文獻(xiàn)信息(PMID)
      HUVEC Cytotoxicity assay 24 h Cytotoxicity against HUVEC after 24 hrs by WST-1 assay, IC50=22 μM 22985958
      mouse Shh-Light II cell Function assay 48 hrs Activation of Shh pathway in mouse Shh-Light II cells assessed as induction of gli1 expression after 48 hrs by renilla luminescence assay, EC50=0.0088 μM 22985958
      Shh-Light II Function assay 48 hrs Activation of Shh pathway in mouse Shh-Light II cells assessed as induction of gli1 expression after 48 hrs by renilla luminescence assay, EC50 = 0.0618 μM. 22985958
      C3H10T1/2 Function assay 6 days Agonist activity at Smo in mouse C3H10T1/2 cells assessed as induction of cell differentiation into osteoblast incubated for 6 days by alkaline phosphatase assay, EC50 = 0.13 μM. 27429255
      NIH/3T3 Function assay Agonist activity at Smo in mouse NIH/3T3 cells transfected with Gli-dependent firefly luciferase reporter assessed as stimulation of Gli transcription factor, EC50 = 0.03 μM. 27429255
      A673 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells 29435139
      Saos-2 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells 29435139
      BT-37 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells 29435139
      RD qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells 29435139
      SK-N-SH qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells 29435139
      BT-12 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells 29435139
      MG 63 (6-TG R) qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells 29435139
      NB1643 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells 29435139
      OHS-50 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells 29435139
      SJ-GBM2 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells 29435139
      SK-N-MC qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells 29435139
      NB-EBc1 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells 29435139
      Rh18 qHTS assay qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells 29435139
      點(diǎn)擊查看更多細(xì)胞系數(shù)據(jù)

      生物活性

      產(chǎn)品描述 SAG (Smoothened Agonist) HCl是一種細(xì)胞滲透性Smoothened (Smo)激動劑,其在Shh-LIGHT2細(xì)胞中的EC50約為3 nM。
      靶點(diǎn)
      Smoothened [1]
      (mouse cultured cell assay)
      3 nM(EC50)
      體外研究(In Vitro)
      體外研究活性

      SAG通過直接結(jié)合到Smo螺旋束調(diào)控Smo活性。[1]

      SAG以GRK2依賴的方式誘導(dǎo)通過Gli的Smo-依賴性信號。[2]

      SAG(1 nM)也會誘導(dǎo)神經(jīng)元和神經(jīng)膠質(zhì)前體細(xì)胞的增殖,而不影響新生細(xì)胞的分化模式。[3]

      實(shí)驗(yàn)圖片 檢測方法 檢測指標(biāo) 實(shí)驗(yàn)圖片 PMID
      Western blot LC3I / LC3II 23504944
      Immunofluorescence Smo acetylated alpha tubulin 25636740
      體內(nèi)研究(In Vivo)
      體內(nèi)研究活性

      在成年大鼠海馬中,SAG (2.5 nM)腦室內(nèi)給藥顯著增加新生細(xì)胞的數(shù)量,并延長海馬細(xì)胞的存活時間。[3]

      在小鼠中,SAG (20 μg/g, i.p.)有效防止GC-誘導(dǎo)的新生小腦發(fā)育異常。[4]

      動物實(shí)驗(yàn) Animal Models 大鼠
      Dosages 2.5 nM
      Administration 側(cè)腦室給藥
      NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
      NCT05937178 Recruiting
      Hepatitis B Chronic
      Huashan Hospital|The First Affiliated Hospital of Anhui Medical University|Anhui Provincial Hospital|Beijing YouAn Hospital|Peking University People''s Hospital|Peking University First Hospital|Xiamen Hospital of Traditional Chinese Medicine|First Affiliated Hospital of Fujian Medical University|LanZhou University|Third Affiliated Hospital Sun Yat-Sen University|First Affiliated Hospital of Guangxi Medical University|The Affiliated Hospital Of Guizhou Medical University|Hainan General Hospital|Hebei Medical University Third Hospital|The First Affiliated Hospital of Henan University of Traditional Chinese Medicine|Henan Provincial People''s Hospital|The Second Affiliated Hospital of Harbin Medical University|Tongji Hospital|Wuhan Union Hospital China|Renmin Hospital of Wuhan University|Central South University|Xiangya Hospital of Central South University|The First Hospital of Jilin University|the Second Hospital of Nangjing|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|The First Affiliated Hospital with Nanjing Medical University|The Affiliated Hospital of Xuzhou Medical University|The First Affiliated Hospital of Nanchang University|Shengjing Hospital|Qingdao Sixth People''s Hospital|Shandong Provincial Hospital|The Second Hospital of Shandong University|The First Affiliated Hospital of Shanxi Medical University|Tang-Du Hospital|First Affiliated Hospital Xi''an Jiaotong University|Ruijin Hospital|West China Hospital|Tianjin Second People''s Hospital|First Affiliated Hospital of Xinjiang Medical University|The First People''s Hospital of Yunnan|Shulan (Hangzhou) Hospital|Zhejiang University|Southwest Hospital China|The Second Affiliated Hospital of Chongqing Medical University|Sichuan Provincial People''s Hospital
      January 31 2023 --
      NCT05701592 Recruiting
      Posterior Cruciate Ligament Tear
      Konrad Malinowski MD|Artromedical Konrad Malinowski Clinic
      December 20 2022 --
      NCT03645044 Active not recruiting
      Hiv|HBV Coinfection
      University of Melbourne|National Health and Medical Research Council Australia|The University of Western Australia|University of Adelaide|The HIV Netherlands Australia Thailand Research Collaboration|University of Malaya|YR Gaitonde Centre for AIDS Research and Education|Melbourne Health
      May 24 2018 --
      • [1]https://pubmed.ncbi.nlm.nih.gov/12391318/
      • [2]https://pubmed.ncbi.nlm.nih.gov/16908539/
      • [3]https://pubmed.ncbi.nlm.nih.gov/20600593/
      • [4]https://pubmed.ncbi.nlm.nih.gov/22013124/

      化學(xué)信息&溶解度

      分子量 526.52 分子式

      C28H29Cl2N3OS

      CAS號 2095432-58-7 SDF Download SAG Hydrochloride SDF
      Smiles CNC1CCC(CC1)N(CC2=CC(=CC=C2)C3=CC=NC=C3)C(=O)C4=C(C5=CC=CC=C5S4)Cl.Cl
      儲存條件(自收到貨起)

      體外溶解度
      批次:

      DMSO : 82 mg/mL ( (155.73 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO)

      Water : 50 mg/mL (94.96 mM)

      Ethanol : 27 mg/mL (51.28 mM)

      摩爾濃度計算器

      體內(nèi)溶解配方
      批次:

      現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑

      動物體內(nèi)配方計算器

      實(shí)驗(yàn)計算

      摩爾濃度計算器

      質(zhì)量 濃度 體積 分子量

      動物體內(nèi)配方計算器(澄清溶液)

      第一步:請輸入基本實(shí)驗(yàn)信息(考慮到實(shí)驗(yàn)過程中的損耗,建議多配一只動物的藥量)

      mg/kg g μL

      第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)

      % DMSO % % Tween 80 % ddH2O
      %DMSO %

      計算結(jié)果:

      工作液濃度: mg/ml;

      DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);

      體內(nèi)配方配制方法:μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。

      體內(nèi)配方配制方法:μL DMSO母液,加入μL Corn oil,混勻澄清。

      注意:1. 首先保證母液是澄清的;
      2.一定要按照順序依次將溶劑加入,進(jìn)行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。

      技術(shù)支持

      在訂購、運(yùn)輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術(shù)支持郵箱[email protected],直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。

      操作手冊

      如果有其他問題,請給我們留言。

      * 必填項(xiàng)

      請輸入您的姓名
      請輸入您的郵箱地址 請輸入一個有效的郵箱地址
      請寫點(diǎn)東西給我們
      在線咨詢
      聯(lián)系我們
        • <dfn id="q240u"></dfn>
        • 五月天堂网| 精品无码一区二区三区爱与 | 1级卖逼网站小黄片 | 国产伦精品一区二区三区新乡影视 | 黄色网址在线免费观看 |